IP Library › Granted Patent US 9,149,610
Granted Patent B2
US 9,149,610 · App. 13/158,757 · Granted Oct 6, 2015

Method and apparatus for improving delivery of an agent to a kidney

Inventors: Binh T Nguyen (Newark, CA); Paul M Consigny (San Jose, CA); Randy Shen (Sunnyvale, CA); Michael J Leonard (Palo Alto, CA)
Assignee: Abbott Cardiovascular Systems Inc.
A61M25/10A61F2/013A61L2300/432A61M25/04A61M2025/0057A61M2025/0073A61M2025/105A61M2206/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,149,610
App. No.
13/158,757
Granted
Oct 6, 2015
Kind
B2
Abstract

Methods for more uniformly delivering drugs or other treatment agents locally to the vasculature of a mammal are disclosed. These methods use one or more strategies to facilitate rapid mixing with the blood flowing past a device or otherwise improve the uniformity of drug delivery. Some of these strategies employ medical devices with diffusion members.

Claims (18)

1. A device comprising:

a catheter including;

a main body,

a self-expanding diffusion member connected to the main body, the self-expanding diffusion member having (1) a closed proximal portion operable to hold a fluid therein; (2) a distal facing surface that is defined by an edge joining the distal facing surface to the closed proximal portion, and (3) a plurality of delivery ports formed within the distal facing surface, and wherein the self-expanding diffusion member is dimensioned to provide from 60 percent to 90 percent occlusion of a blood vessel of a mammal, and

a drug delivery lumen located in the main body, wherein the drug delivery lumen is in fluid communication with the drug delivery ports via the closed proximal portion such that a drug can be delivered from the plurality of delivery ports in a generally distal direction,

wherein the device is adapted for percutaneous delivery into the vasculature of a mammal and adapted to expand the self-expanding diffusion member within the vessel.

2. The device of claim 1 wherein the drug delivery lumen is proximal to the self-expanding diffusion member.

3. The device of claim 1 wherein the self-expanding diffusion member has a diameter between 60 and 90 percent of the vessel diameter.

4. The device of claim 1 wherein the device further comprises a deployment sheath that is movably affixed substantially coaxially to the main body.

5. The device of claim 4 wherein the self-expanding diffusion member is connected to a distal end of the main body at the closed proximal portion of the self-expanding diffusion member.

6. A device comprising a catheter including

a main body,

an expandable diffusion member connected to the main body, the expandable diffusion member having a proximal end and a distal end, and wherein the proximal end is closed such that the proximal end is operable to occlude a blood vessel within which the device is positioned and the distal end forms a distal facing surface that is defined by an edge, the distal facing surface having a plurality of delivery ports facing a generally distal direction, and

a drug delivery lumen located in the expandable diffusion member and terminating at a point proximal to the face, wherein the drug delivery lumen is in fluid communication with the drug delivery ports such that a drug can be delivered from the plurality of delivery ports in a generally distal direction,

wherein the device is adapted for percutaneous delivery into the vasculature of a mammal and adapted to expand the expandable diffusion member within a blood vessel of a mammal.

7. The device of claim 6 wherein the expandable diffusion member has a diameter between 20 and 95 percent, 40 and 93 percent, or 60 and 90 percent of the vessel diameter.

8. The device of claim 6 wherein the expandable diffusion member comprises tabs attached near the edge, which is between the distal end of the expandable diffusion member and sides of the proximal end of the expandable diffusion member.

9. The device of claim 6 wherein the distal end comprises four or more delivery ports.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2011
From: LEONARD, MICHAEL J.; NGUYEN, BINH T.; CONSIGNY, PAUL M; SHEN, RANDY
To: ABBOTT CARDIOVASCULAR SYSTEMS INC.
Reel/Frame 026434/0218 →
Continuity (4)
Continuation In Part 11756376 · May 31, 2007
Continuation In Part 12902405 · Oct 12, 2010
Continuation 13154258 · Jun 6, 2011
Related Publication 20110245766A1 · Oct 6, 2011